Abstract

Objective: To describe the implementation of a multi-step antimicrobial stewardship program in a haemato-oncology and stem cell transplantation program unit. Methods: Pre-post quasi-experimental study with two interrupted time-series analyses, conducted between 01/01/2019 and 31/12/2022 in the Paediatric Haemato-Oncology Unit of the Padua Paediatric Hospital. The interventions were: (1) 02/2020: dissemination of febrile neutropenia clinical pathways, (2) April 2021: provision of the clinical pathways via a customized App (Firstline.org) and implementation of a twice-a-week prospective audit and feedback. The main outcome was antibiotic consumption measured by days of administered therapy (DOTs)/1000 patients’ days for all antibiotics and most used molecules. Results: The first intervention (clinical pathways) resulted in a decrease in the overall antibiotic use by the haemato-oncology unit, with an abrupt reduction of 3-gen cephalosporins in favor of piperacillin-tazobactam, as indicated by the clinical pathways. Meropenem and glycopeptide use did not vary. The second intervention (antimicrobial stewardship) further decreased total antibiotic consumption, and a significant decline in meropenem, amikacin, and glycopeptides was achieved. Conclusions: Multi-step stewardship based on guidelines dissemination, multidisciplinary team intervention and collaboration (“handshake” stewardship) was highly effective in optimizing guidelines adherence and reducing overprescriptions in a fragile patient cohort.

Details

Title
Impact of a two step antimicrobial stewardship program in a paediatric haematology and oncology unit
Author
Liberati, Cecilia 1 ; Barbieri, Elisa 1 ; Cavagnero, Francesca 1 ; Petris, Maria Grazia 2 ; Brigadoi, Giulia 1 ; Reggiani, Giulia 2 ; De Pieri, Marica 1 ; Pierobon, Marta 2 ; Marzollo, Antonio 2 ; Gabelli, Maria 2 ; Trivellato, Sabrina 3 ; Rigotti, Erika 4 ; Opri, Francesca 4 ; Mengato, Daniele 3 ; Venturini, Francesca 3 ; De Canale, Ettore 5 ; Del Vecchio, Claudia 5 ; Giaquinto, Carlo 1 ; Carrara, Elena 6 ; Tacconelli, Evelina 6 ; Biffi, Alessandra 7 ; Donà, Daniele 1 

 University of Padova, Division of Paediatric Infectious Diseases, Department of Women’s and Children’s Health, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 Padua University Hospital, Paediatric Haematology, Oncology and Stem Cell Transplant, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 Azienda Ospedale-Università di Padova, Hospital Pharmacy Unit, Padua, Italy (GRID:grid.411474.3) (ISNI:0000 0004 1760 2630) 
 University of Verona, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, Verona, Italy (GRID:grid.5611.3) (ISNI:0000 0004 1763 1124) 
 Padua University Hospital, Microbiology and Virology Unit, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 University of Verona, Division of Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy (GRID:grid.5611.3) (ISNI:0000 0004 1763 1124) 
 University of Padova, Division of Paediatric Haematology, Oncology and Stem Cell Transplant, Department for Women’s and Children’s Health, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
Pages
29296
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3133073429
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.